Rambam AG

Rambam AG is a Swiss-based venture studio and accelerator platform for breakthrough drug discovery and development. Our partnership with the US and European venture companies and direct access to Expert Systems’ technology consulting platform brings together biotech venture funding and rational program design and execution to translate scientific insights into novel medicines. We support expedient 2-year progress from company formation to early clinical candidates with ultra efficient seed and series A capital and low attrition. Rambam's portfolio of companies and programs is supported by a core group of seasoned industrial experts, program managers and dedicated functional area specialists in Europe (Switzerland, Portugal, Germany) and the US. Rambam brings to Europe a uniquely streamlined and agile operating model based on multiple success stories stemming from over 20 programs and companies co-funded with OrbiMed, BGV and other partners.